(No ratings)
Dr. Rachana Singh, MS, MD is a neonatologist in Melrose, MA specializing in neonatology and general pediatrics. She graduated from Medical College Baroda. Dr. Rachana Singh, MS, MD is affiliated with Tufts Medicine and Boston Children's Hospital.
Dr. Rachana Singh, MS, MD graduated from Medical College Baroda. She completed residency at New York Methodist Hospital. She is certified by the Board Certification: Neonatal-Perinatal Medicine and has a state license in Massachusetts.
Medical School: Medical College Baroda
Residency: New York Methodist Hospital
Board Certification: Board Certification: Neonatal-Perinatal Medicine
Licensed In: Massachusetts
Dr. Rachana Singh, MS, MD is associated with these hospitals and organizations:
Dr. Rachana Singh, MS, MD does not have any reviews yet, be the first to leave a review of Dr. Rachana Singh, MS, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Rachana Singh, MS, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Baxter Healthcare |
$1,661
IPS - Nutrition $1,599 |
$62 |
|---|---|---|
| Chiesi USA, Inc. |
$194
Curosurf $194 |
| Consulting Fee | $1,420 |
|---|---|
| Food and Beverage | $355 |
| Gift | $80 |
Dr. Rachana Singh, MS, MD has received 23 research payments totaling $236,484.
Dr. Rachana Singh's areas of specialization are neonatology and general pediatrics. Dr. Singh (or staff) speaks the following languages: Gujarati and Hindi. Her hospital/clinic affiliations include Tufts Medicine and Boston Children's Hospital. She attended Medical College Baroda and then went on to complete her residency at New York Methodist Hospital. Dr. Singh has received the following distinctions: Distinguished Performer Quality Category Baystate Health, Springfield, MA; Notable Teaching Citation Class of 2015, Tufts University School of Medicine, Boston, MA; and Best First Year Resident Award New York Methodist Hospital, Brooklyn, NY. She is not accepting new patients at this time according to Tufts Medicine.